Federal Register / Vol. 83, No. 10 / Tuesday, January 16, 2018 / Notices 2159 

adobeconnect.cdc.gov/e9qxcduyr42/ 

event/registration.html; Dial in number: 

866–817–6648; Participant code: 

48225449 (100 seats). 

DATES: The meeting will be held on 

February 13, 2018, 2:00 p.m. to 5:00 

p.m., EST. 

ADDRESSES: Centers for Disease Control 

and Prevention (CDC), Global 

Communications Center, Building 21, 

Room 6116, 1600 Clifton Road NE, 

Atlanta, Georgia 30329. 

FOR FURTHER INFORMATION CONTACT: 

Dometa Ouisley, Office of Science and 

Public Health Practice, Centers for 

Disease Control and Prevention, 1600 

Clifton Road NE, Mailstop D–44, 

Atlanta, Georgia 30329, Telephone: 

(404) 639–7450; Facsimile: (404) 471– 

8772; Email: OPHPR.BSC.Questions@

cdc.gov. 

SUPPLEMENTARY INFORMATION: 

Purpose: This Board is charged with 

providing advice and guidance to the 

Secretary, Department of Health and 

Human Services (HHS), the Assistant 

Secretary for Health (ASH), the Director, 

Centers for Disease Control and 

Prevention (CDC), and the Director, 

Office of Public Health Preparedness 

and Response (OPHPR), concerning 

strategies and goals for the programs 

and research within OPHPR, monitoring 

the overall strategic direction and focus 

of the OPHPR Divisions and Offices, 

and administration and oversight of 

peer review for OPHPR scientific 

programs. For additional information 

about the Board, please visit: http://

www.cdc.gov/phpr/science/ 

counselors.htm. 

Matters to be Considered: The agenda 

will include briefings and BSC 

deliberation on the following topics: 

interval updates from OPHPR Divisions 

and Offices, including responses to 

issues raised by the Board during the 

October 2017 in-person BSC, OPHPR 

meeting; updates from the Biological 

Agent Containment working group; and 

proposed agenda items for the May 

9–10, 2018, in-person BSC meeting. 

Agenda items are subject to change as 

priorities dictate. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both the 

Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2018–00540 Filed 1–12–18; 8:45 am] 

BILLING CODE 4163–19–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Advisory Board on Radiation and 

Worker Health (ABRWH or the 

Advisory Board), National Institute for 

Occupational Safety and Health 

(NIOSH) 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice of meeting. 

SUMMARY: In accordance with the 

Federal Advisory Committee Act), the 

CDC, announces the following meeting 

of the Advisory Board on Radiation and 

Worker Health (ABRWH). This meeting 

is open to the public, but without a 

public comment period. The public is 

welcome to submit written comments in 

advance of the meeting to the contact 

person below. Written comments 

received in advance of the meeting will 

be included in the official record of the 

meeting. The public is also welcome to 

listen to the meeting by joining the 

teleconference at the USA toll-free, dialin number at 1–866–659–0537; the pass 

code is 9933701. The conference line 

has 150 ports for callers. 

DATES: The meeting will be held on 

February 21, 2018, 11:00 a.m. to 1:00 

p.m. EST. 

ADDRESSES: Audio Conference Call via 

FTS Conferencing. The USA toll-free 

dial-in number is 1–866–659–0537; the 

pass code is 9933701. 

FOR FURTHER INFORMATION CONTACT: 

Theodore Katz, MPA, Designated 

Federal Officer, NIOSH, CDC, 1600 

Clifton Road, Mailstop E–20, Atlanta, 

Georgia 30333, Telephone (513)533– 

6800, Toll Free 1(800)CDC–INFO, Email 

ocas@cdc.gov. 

SUPPLEMENTARY INFORMATION: 

Background: The Advisory Board was 

established under the Energy Employees 

Occupational Illness Compensation 

Program Act of 2000 to advise the 

President on a variety of policy and 

technical functions required to 

implement and effectively manage the 

new compensation program. Key 

functions of the Advisory Board include 

providing advice on the development of 

probability of causation guidelines 

which have been promulgated by the 

Department of Health and Human 

Services (HHS) as a final rule, advice on 

methods of dose reconstruction which 

have also been promulgated by HHS as 

a final rule, advice on the scientific 

validity and quality of dose estimation 

and reconstruction efforts being 

performed for purposes of the 

compensation program, and advice on 

petitions to add classes of workers to the 

Special Exposure Cohort (SEC). In 

December 2000, the President delegated 

responsibility for funding, staffing, and 

operating the Advisory Board to HHS, 

which subsequently delegated this 

authority to the CDC. NIOSH 

implements this responsibility for CDC. 

The charter was issued on August 3, 

2001, renewed at appropriate intervals, 

rechartered on March 22, 2016, 

pursuant to Executive Order 13708, and 

will expire on March 22, 2018. 

Purpose: This Advisory Board is 

charged with (a) providing advice to the 

Secretary, HHS, on the development of 

guidelines under Executive Order 

13179; (b) providing advice to the 

Secretary, HHS, on the scientific 

validity and quality of dose 

reconstruction efforts performed for this 

program; and (c) upon request by the 

Secretary, HHS, advising the Secretary 

on whether there is a class of employees 

at any Department of Energy facility 

who were exposed to radiation but for 

whom it is not feasible to estimate their 

radiation dose, and on whether there is 

reasonable likelihood that such 

radiation doses may have endangered 

the health of members of this class. 

Matters to be Considered: The agenda 

will include discussions on: Work 

Group and Subcommittee Reports; 

Update on the Status of SEC Petitions; 

Plans for the April 2018 Advisory Board 

Meeting; and Advisory Board 

Correspondence. Agenda items are 

subject to change as priorities dictate. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both the 

Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2018–00541 Filed 1–12–18; 8:45 am] 

BILLING CODE 4163–19–P 


daltland on DSKBBV9HB2PROD with NOTICES